Press Releases

Date Title and Summary  
Toggle Summary Geron Appoints Vice President, Pharmacovigilance and Drug Safety
MENLO PARK, Calif. , Jan. 17, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the hiring of the first of several key leadership positions as it rebuilds the in-house development team to support its plans to initiate a Phase 3 clinical trial of imetelstat in lower risk